Evaluation of an in utero through lactational exposure protocol for detection of estrogenic effects of ethinyl estradiol on the offspring of rats: Preliminary trial

Reproductive Toxicology

Volumn 17, Issue 3, 2003, Pages 335-343

  Sawaki, Masakuni ^a   Noda, Shuji ^a   Muroi, Takako ^a   Mitoma, Hideo ^a   Takakura, Saori ^a   Sakamoto, Satoko ^a   Yamasaki, Kanji ^a  

^a CHEMICALS EVALUATION AND RESEARCH INSTITUTE   (Japan)

Author keywords

Cleft phallus; Developmental anomaly; Endocrine disrupter; Ethinyl estradiol; External genitalia; In utero through lactational exposure; Perinatal exposure; Rats

Indexed keywords

ETHINYLESTRADIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BREAST DISEASE; CLEFT PHALLUS; CONTROLLED STUDY; ESTROGEN ACTIVITY; FEMALE; GENITAL MALFORMATION; HISTOPATHOLOGY; LACTATION; MALE; NONHUMAN; PERINATAL PERIOD; PRENATAL EXPOSURE; PROSTATE DISEASE; RAT; SEMINAL VESICLE DISEASE; TESTIS DISEASE;

EID: 0037809295     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(03)00005-4     Document Type: Article

References (26)

1. McLachlan JA. Functional toxicology: a new approach to detect functionally active xenobiotics. Environ Health Perspect 1993;101:386-7.
2. McLachlan JA, Korach KS. Estrogens in the environment global health implications. Environ Health Perspect 1995;103(Suppl 7):3-4.
3. OECD. OECD guidance and protocol for the prevalidation of the rat uterotrophic screening assay. ENV/JIVUTG/EDTA(99)2/ANN1. Joint Meeting of the Chemicals Committee and the Working Party on Chemicals. Paris: OECD; 1999.
4. Stoker TE, Parks LG, Gray LE, Cooper PL. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid function in the male rat. A focus on the EDSTAC recommendations. Crit Rev Toxicol 2000;30:197-252.
5. Gray Jr LE. Tiered screening and testing strategy for xenoestrogens and antiandrogens. Toxicol Lett 1998;102-103:677-80.
6. Gill WB, Schumacher GF, Bibbo M. Structural and functional abnormalities in the sex organs of male offspring of mothers treated with diethylstilbestrol (DES). J Reprod Med 1976;16:147-53.
7. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971;284:878-81.
8. Ben-Baruch G, Menczer J, Mashiack S, Serr DM. Uterine anomalies in diethylstilbestrol-exposed women with fertility disorders. Acta Obstet Gynec Scand 1981;60:395-7.
9. Kaufman RH, Binder GL, Gray PM, Adam E. Upper genital tract changes associated with exposure in utero to diethylstilbestrol. Am J Obstet Gynec 1977;128:51-9.
10. Rothschild TC, Calhoon RE, Boylan ES. Effects of diethylstilbestrol exposure in utero on the genital tracts of female ACI rats. Exp Mol Pathol 1988;48:59-76.
11. Henry C, Miller RK, Baggs RB. Direct fetal injections of diethylstilbestrol and 17β-estradiol: a method for investigating their teratogenicity. Teratology 1984;29:297-304.
12. Biegel LB, Flaws JA, Hirshfield AN, et al. Ninety-day feeding and one-generation reproduction study in Crl:CD BR rats with 17β-estradiol. Toxicol Sci 1998;44:116-42.
13. Gray K, Bullock B, Dickson R, et al. Potentiation of diethylstilbestrol-induced alterations in the female mouse reproductive tract by transforming growth factor-α transgene expression. Mol Carcinog 1996;17:163-73.
14. Miyagawa S, Buchanan DL, Sato T, et al. Characterization of diethylstilbestrol-induced hypospadias in female mice. Anat Rec 2002;266:43-50.
15. Lamb C, Newbold RR, McLachlan JA. Visualization by light and scanning electron microscopy of reproductive tract lesions in female mice treated transplacentally with diethylstilbestrol. Cancer Res 1981;41:4057-62.
16. OECD. Protocol for the conduct of the OECD rodent uterotrophic assay: second stage of the OECD work of the validation of the rodent uterotrophic assay. Paris: OECD; 2000.
17. OECD. Protocol for investigating the efficacy of the enhanced TG407 test guideline (phase 2), rationale for the investigation, and description of the protocol. Paris: OECD; 2000.
18. Yamasaki K, Sawaki M, Noda S, Imatanaka N, Takatsuki M. Subacute oral toxicity study of ethynylestradiol and bisphenol A, based on the draft protocol for the 'Enhanced OECD Test Guideline No. 407'. Arch Toxicol 2002;76:65-74.
19. Andrews P, Freyberger A, Hartmann E, et al. Sensitive detection of the endocrine effects of the estrogen analogue ethinylestradiol using a modified enhanced subacute rat study protocol (OECD Test Guideline No. 407). Arch Toxicol 2002;76:194-202.
20. Gray LE, Wolf C, Mann P, Ostby JS. In utero exposure to low doses of 2,3,7,8-tetrachlorodibenzo-p-dioxin alters reproductive development of female Long Evans hooded rat offspring. Toxicol Appl Pharmacol 1997;146:237-44.
21. Wolf CJ, Hotchkiss A, Ostby JS, LeBlanc GA, Gray Jr LE. Effects of prenatal testosterone propionate on the sexual development of male and female rats: a dose-response study. Toxicol Sci 2002;65:71-86.
22. FINAL Report of the Endocrine Disruptors Low-Dose Peer Review. National Institute of Environmental Health Sciences, National Toxicology Program, Research Triangle Park, NC; 2001 (http://ntpserver.niehs.nih.gov/htdocs/liason/LowDoseWebPage.html).
23. Talsness C, Fialkowski O, Gericke C, Merker H-J, Chahoud I. The effects of low and high doses of bisphenol A on the reproductive system of female and male rat offspring. Cong Anom 2000;40(Suppl):94-107.
24. Henry EC, Miller RK. The antiestrogen LY117018 is estrogenic in the fetal rat. Teratology 1986;34:59-63.
25. Hajek RA, Robertson AD, Johnston DA, et al. During development, 17β-estradiol is a potent estrogen and carcinogen. Environ Health Perspect 1997;105(Suppl 3):577-8.
26. McIntyre BS, Barlow NJ, Foster PM. Androgen-mediated development in male rat offspring exposed to flutamide in utero: permanence and correlation of early postnatal changes in anogenital distance and nipple retention with malformations in androgen-dependent tissues. Toxicol Sci 2001;62:236-49.